Rheumatology leaders say FDA biosimilar interchangeability guidance a balanced approach
ATLANTA - The Food and Drug Administration (FDA) has released a draft guidance on biosimilar interchangeability titled "Considerations in Demonstrating Interchangeability With a Reference Product"...







